{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360011144465304576.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.18632/oncotarget.7374"}},{"identifier":{"@type":"URI","@value":"https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.7374"}}],"dc:title":[{"@value":"Distinct features between<i>MLH1</i>-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380011144465304576","@type":"Researcher","foaf:name":[{"@value":"Jung Ho Kim"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011144465304577","@type":"Researcher","foaf:name":[{"@value":"Jeong Mo Bae"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011144465304578","@type":"Researcher","foaf:name":[{"@value":"Nam-Yun Cho"}],"jpcoar:affiliationName":[{"@value":"Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011144465304579","@type":"Researcher","foaf:name":[{"@value":"Gyeong Hoon Kang"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea"},{"@value":"Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"19492553"}],"prism:publicationName":[{"@value":"Oncotarget"}],"dc:publisher":[{"@value":"Impact Journals, LLC"}],"prism:publicationDate":"2016-02-13","prism:volume":"7","prism:number":"12","prism:startingPage":"14095","prism:endingPage":"14111"},"reviewed":"false","url":[{"@id":"https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.7374"}],"createdAt":"2016-02-13","modifiedAt":"2022-06-04","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004238273270144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"<i>ZNF350</i> promoter methylation accelerates colon cancer cell migration"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.18632/oncotarget.7374"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.26353_references_DOI_ZhJVzIPme0r6OHLqQJNMatCNxBI"}]}